Breast Cancer Episode 27: Perioperative atezolizumab does not improve event-free survival in early-stage triple negative breast cancer: results of the phase III GeparDouze trial wondermedia 19 February 2025
Breast Cancer Episode 26: Perioperative pembrolizumab for early stage triple negative breast cancer: overall survival and biomarker analyses of KEYNOTE-522 Admin 6 February 2025
Breast Cancer Episode 25: Elacestrant for CDK4/6 inhibitor pretreated patients with HR+/HER2- advanced breast cancer: real-world data and updated results from the EMERALD trial wondermedia 22 January 2025
Breast Cancer Episode 24: Olaparib as a treatment option in germline BRCA-mutated, HER2- metastatic breast cancer: the OlympiAD trial 2 May 2024
Breast Cancer Episode 23: ESMO clinical practice guidelines for early-stage breast cancer 25 April 2024
Breast Cancer Episode 22: Neoadjuvant and adjuvant pembrolizumab in early-stage high-risk ER+/HER2- breast cancer: KEYNOTE-756 18 April 2024
Breast Cancer Episode 21: Neoadjuvant immunotherapy for high-risk ER+/HER2- breast cancer: insights from the CheckMate-7FL trial 28 March 2024
Breast Cancer Episode 20: Primary results from the TROPION-Breast01 study on Dato-DXd in HR+/HER2- metastatic breast cancer treatment 21 March 2024
Breast Cancer Episode 19: Efficacy of ADC therapy in HER2 low breast cancer: updated results from DESTINY-Breast04 14 March 2024
Breast Cancer Episode 18: Olaparib increases ORR in advanced cancers with BRCA1/2 but not CHEK2 and ATM mutations, the PRECISION 2 trial 7 March 2024
